UB Paderborn / Katalog / Suche / in CDI

Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement

Journal of thrombosis and haemostasis, 2003-05, Vol.1 (5), p.896-906

2003

Volltextzugriff (PDF)

Multinational Study of Reliability and Validity of the King's Health Questionnaire in Patients with Overactive Bladder

Quality of life research, 2003-06, Vol.12 (4), p.427-442

2003

Volltextzugriff (PDF)

False positive results: a challenge for psychiatric screening in primary care

The American journal of psychiatry, 1997-10, Vol.154 (10), p.1462-1464

1997

Volltextzugriff (PDF)

Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder

The American journal of managed care, 2002-12, Vol.8 (19 Suppl), p.S616-S630

2002

Volltextzugriff (PDF)

Health-Related Quality of Life of Patients with Overactive Bladder Receiving Immediate-Release Tolterodine

The European journal of health economics, 2001, Vol.2 (2), p.69-75

2001

Volltextzugriff (PDF)

How much is enough and who says so? The case of the King's Health Questionnaire and overactive bladder

BJOG : an international journal of obstetrics and gynaecology, 2004-06, Vol.111 (6), p.605-612

2004

Volltextzugriff (PDF)

Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS

PharmacoEconomics, 2001, Vol.19 (5 Pt 2), p.535-550

2001

Volltextzugriff (PDF)

The Validation of Patient-Rated Global Assessments of Treatment Benefit, Satisfaction, and Willingness to Continue—The BSW

Value in health, 2005-11, Vol.8, p.S25-S34

2005

Volltextzugriff (PDF)

Two approaches to comparing hospital charges between cadaveric renal transplant patients who received Orthoclone OKT® 3 sterile solution or Atgam® sterile solution for induction therapy

Clinical therapeutics, 1995-07, Vol.17 (4), p.749-769

1995

Volltextzugriff (PDF)

Commercial drug compendium information: a First World/Third World comparison

International journal of health services, 1988-01, Vol.18 (4), p.587

1988

Volltextzugriff (PDF)

The importance of considering non-monetary costs and benefits in selecting pharmacologic interventions in mental health

Psychopharmacology bulletin, 1995, Vol.31 (4), p.727

Pleil, A M

1995

Volltextzugriff (PDF)

Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults

Medical devices (Auckland, N.Z.), 2014-01, Vol.7 (default), p.61-71

2014

Volltextzugriff (PDF)

Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder

The American journal of managed care, 2002-12, Vol.8 (19 Suppl), p.S608-S615

2002

Volltextzugriff (PDF)

Incorporating individualized quality of life measures in the evaluation of pharmacy services: the INCOMPASS framework

Pharmacy practice management quarterly, 1998-01, Vol.17 (4), p.54

1998

Volltextzugriff (PDF)

PEY17 MODELING TREATMENTS FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE RELATED MACULAR DEGENERATION: COST-EFFECTIVENESS METHODS

Value in health, 2005-11, Vol.8 (6), p.A179-A179

2005

Volltextzugriff (PDF)

PEY11 COST-EFFECTIVENESS MODEL FORAGE-RELATED MACULAR DEGENERATION: COMPARING EARLY AND LATE MACUGEN TREATMENT

Value in health, 2005-11, Vol.8 (6), p.A177-A177

2005

Volltextzugriff (PDF)

PEY9 COST-EFFECTIVENESS MODEL FORAGE-RELATED MACULAR DEGENERATION: COMPARING MACUGEN TO VISUDYNE

Value in health, 2005-11, Vol.8 (6), p.A176-A177

2005

Volltextzugriff (PDF)

PRK13 REGIONAL SIMILARITIES IN IMPROVEMENT AND PERSISTENCE OF SHORT-TERM HEALTH-RELATED QUALITY OF LIFE EFFECT OF TOLTERODINE ON OVERACTIVE BLADDER PATIENTS

Value in health, 2002-11, Vol.5 (6), p.585-585

2002

Volltextzugriff (PDF)

PUK11 EFFECTS OF LONG-TERM TOLTERODINE TREATMENT ON PHYSICAL AND SYMPTOM ASPECTS OF HEALTH-RELATED QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS

Value in health, 2002-05, Vol.5 (3), p.278-278

2002

Volltextzugriff (PDF)

TPDM4: MODELING LIFETIME TREATMENT COSTS OF HIV/AIDS PATIENTS

Value in health, 1999-05, Vol.2 (3), p.151-151

1999

Volltextzugriff (PDF)

TPCT7: CEFPODOXIME PROXETIL 100mg VERSUS CEFPODOXIME PROXETIL 200mg IN THE TREATMENT OF ACUTE BACTERIAL EXACERBATION OF CHRONIC BRONCHITIS IN ADULT PATIENTS

Value in health, 1999-05, Vol.2 (3), p.155-155

1999

Volltextzugriff (PDF)

Commercial drug compendium information: a First World/Third World comparison

International journal of health services, 1988-01, Vol.18 (1988), p.587-602

1988

Volltextzugriff (PDF)

Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols

Analytica chimica acta, 2018-09, Vol.1024, p.18-38

2018

Volltextzugriff (PDF)

Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment

Patient preference and adherence, 2020-01, Vol.14, p.781-793

2020

Volltextzugriff (PDF)

Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain

Neuropsychopharmacology (New York, N.Y.), 2016-07, Vol.41 (8), p.2122-2132

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement

Multinational Study of Reliability and Validity of the King's Health Questionnaire in Patients with Overactive Bladder

False positive results: a challenge for psychiatric screening in primary care

Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder

Health-Related Quality of Life of Patients with Overactive Bladder Receiving Immediate-Release Tolterodine

How much is enough and who says so? The case of the King's Health Questionnaire and overactive bladder

Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS

The Validation of Patient-Rated Global Assessments of Treatment Benefit, Satisfaction, and Willingness to Continue—The BSW

Two approaches to comparing hospital charges between cadaveric renal transplant patients who received Orthoclone OKT® 3 sterile solution or Atgam® sterile solution for induction therapy

Commercial drug compendium information: a First World/Third World comparison

The importance of considering non-monetary costs and benefits in selecting pharmacologic interventions in mental health

Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults

Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder

Incorporating individualized quality of life measures in the evaluation of pharmacy services: the INCOMPASS framework

PEY17 MODELING TREATMENTS FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE RELATED MACULAR DEGENERATION: COST-EFFECTIVENESS METHODS

PEY11 COST-EFFECTIVENESS MODEL FORAGE-RELATED MACULAR DEGENERATION: COMPARING EARLY AND LATE MACUGEN TREATMENT

PEY9 COST-EFFECTIVENESS MODEL FORAGE-RELATED MACULAR DEGENERATION: COMPARING MACUGEN TO VISUDYNE

PRK13 REGIONAL SIMILARITIES IN IMPROVEMENT AND PERSISTENCE OF SHORT-TERM HEALTH-RELATED QUALITY OF LIFE EFFECT OF TOLTERODINE ON OVERACTIVE BLADDER PATIENTS

PUK11 EFFECTS OF LONG-TERM TOLTERODINE TREATMENT ON PHYSICAL AND SYMPTOM ASPECTS OF HEALTH-RELATED QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS

TPDM4: MODELING LIFETIME TREATMENT COSTS OF HIV/AIDS PATIENTS

TPCT7: CEFPODOXIME PROXETIL 100mg VERSUS CEFPODOXIME PROXETIL 200mg IN THE TREATMENT OF ACUTE BACTERIAL EXACERBATION OF CHRONIC BRONCHITIS IN ADULT PATIENTS

Commercial drug compendium information: a First World/Third World comparison

Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols

Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment

Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain

Suchergebnisse filtern